http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 11 Mar 2026 07:01:17 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/NASA+awards+Redwire+%244+million+for+space+drug+development+research/26142511.html <p>NASA has awarded Redwire Corporation (NYSE: RDW) an additional $4 million to support drug development investigations on the International Space Station using the company's Pharmaceutical In-space Laboratory technology.</p><p>The funding expands an existing task order under a $25 million, five-year contract through NASA's In Space Production Applications program. Redwire will use its PIL-BOX technology to conduct research aimed at developing treatments for diseases including cancer, osteoporosis and obesity.</p><p>The company's PIL-BOX technology has flown 43 units and contributed to growing high-quality crystals in microgravity conditions. Redwire recently supported a cancer therapy investigation led by Aspera Biomedicines that launched aboard the SpaceX Crew-12 http://www.streetinsider.com/Corporate+News/NASA+awards+Redwire+%244+million+for+space+drug+development+research/26142511.html Wed, 11 Mar 2026 07:01:17 -0400 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Press+Releases/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html <p> JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program. </p><p> “The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the http://www.streetinsider.com/Business+Wire/NASA+Awards+Redwire+%244+Million+In+Additional+Funding+to+Support+Trailblazing+Drug+Development+in+Microgravity/26142446.html Wed, 11 Mar 2026 07:00:00 -0400 A.20288896 A.20982585 A.35006980 A.36231064 O.02092487 O.02109591 O.32239304 O.35620221 O.50272815 RDW http://www.streetinsider.com/Upgrades/Truist+Securities+Upgrades+Redwire+%28RDW%29+to+Buy/26128428.html <p>Truist Securities analyst Michael Ciamoli upgraded Redwire (NYSE: RDW) from Hold to Buy with a price target of $15.00 (from $13.00).</p><p>The analyst comments "We are upgrading RDW to BUY from HOLD and lifting our PT to $15 (from $13), 66% upside from current levels. The improving mix and progress on programs, ~33% now in full rate production, and further progression on development programs, gives us more confidence that EAC charges should potentially moderate in the coming periods. We see gross margins improving as product mix continues to shift more favorably to production with our 2026 estimate at 23.3% up from http://www.streetinsider.com/Upgrades/Truist+Securities+Upgrades+Redwire+%28RDW%29+to+Buy/26128428.html Mon, 09 Mar 2026 06:06:37 -0400 RDW http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Upgrades+Redwire+%28RDW%29+to+Buy/26128428.html <p>Truist Securities analyst Michael Ciamoli upgraded Redwire (NYSE: RDW) from Hold to Buy with a price target of $15.00 (from $13.00).</p><p>The analyst comments "We are upgrading RDW to BUY from HOLD and lifting our PT to $15 (from $13), 66% upside from current levels. The improving mix and progress on programs, ~33% now in full rate production, and further progression on development programs, gives us more confidence that EAC charges should potentially moderate in the coming periods. We see gross margins improving as product mix continues to shift more favorably to production with our 2026 estimate at 23.3% up from http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Upgrades+Redwire+%28RDW%29+to+Buy/26128428.html Mon, 09 Mar 2026 06:06:37 -0400 RDW http://www.streetinsider.com/Analyst+PT+Change/Redwire+%28RDW%29+PT+Lowered+to+%2412+at+Jefferies+following+Q4+results/26122886.html <p>Jefferies analyst Greg Konrad lowered the price target on Redwire (NYSE: RDW) to $12.00 (from $13.00) while maintaining a Buy rating.</p><p>The analyst commented, "RDW's Q4 results were like ying and yang. On one hand, order pressures have started to thaw w/ Q4 revs up 56% to $108.8MM (-18% organic) at the upper end of the full year guide underscored by improving demand (1.52X B2B). The flipside is inability to shake negative EACs w/ Adj EBITDA losses accelerating ($18MM loss vs. $9MM a year ago). Improving organic growth trends into 2026 (mid-teens) and mix shifting more toward production remain key catalysts."</p> http://www.streetinsider.com/Analyst+PT+Change/Redwire+%28RDW%29+PT+Lowered+to+%2412+at+Jefferies+following+Q4+results/26122886.html Fri, 06 Mar 2026 09:05:58 -0400 RDW http://www.streetinsider.com/Analyst+Comments/KeyBanc+On+Aerospace+%26+Defense+Stocks+Amid+Iran+Escalation/26121394.html <p>KeyBanc analyst Michael Leshock examines potential implications for the Aerospace & Defense sector if the conflict with Iran escalates into a prolonged war involving boots on the ground.</p><p>The analyst commented: "As the first week of the Iran conflict draws to a close, we provide updated perspectives on the evolving situation and the potential implications across our A&D coverage should the conflict escalate and if U.S. troops are deployed in Iran. In the event of a prolonged war, we see AVAV, RDW, KTOS, and KRMN among the primary beneficiaries, driven by the need to replenish stockpiles and the expanding role of http://www.streetinsider.com/Analyst+Comments/KeyBanc+On+Aerospace+%26+Defense+Stocks+Amid+Iran+Escalation/26121394.html Fri, 06 Mar 2026 04:31:19 -0400 AIR AVAV FLY HEI KRMN KTOS LUNR RDW RKLB SPCE TDG VOYG